Merck Kgaa (MRK.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 11,500,800 | 11,095,100 | 11,172,900 | 10,276,400 | 9,290,600 |
| Cost of Goods | 4,063,900 | 3,559,500 | 3,737,500 | 2,788,300 | 2,385,400 |
| Gross Profit | 7,436,900 | 7,535,600 | 7,435,400 | 7,488,100 | 6,905,200 |
| Operating Expenses | 5,680,800 | 5,382,100 | 5,546,300 | 6,503,000 | 5,799,900 |
| Operating Income | 1,756,100 | 2,153,500 | 1,889,100 | 985,100 | 1,105,300 |
| Interest Expense | 222,700 | 248,000 | 301,200 | N/A | N/A |
| Other Income | 23,600 | -516,900 | -878,900 | -134,000 | -244,200 |
| Pre-tax Income | 1,557,000 | 1,388,600 | 709,000 | 851,100 | 861,100 |
| Income Tax | 392,200 | 179,500 | 130,000 | 222,100 | 219,600 |
| Net Income Continuous | 1,164,800 | 1,209,100 | 579,000 | 617,500 | 650,900 |
| Minority Interests | -7,500 | -6,900 | -12,300 | 11,500 | -9,400 |
| Net Income | $1,157,300 | $1,202,200 | $566,700 | $629,000 | $641,500 |
| EPS Basic Total Ops | 2.66 | 2.77 | 1.31 | 1.42 | 1.46 |
| EPS Basic Continuous Ops | 2.66 | 2.77 | 1.31 | 1.42 | 1.46 |
| EPS Diluted Total Ops | 2.66 | 2.77 | 1.31 | 1.42 | 1.46 |
| EPS Diluted Continuous Ops | 2.66 | 2.77 | 1.31 | 1.42 | 1.46 |
| EBITDA(a) | $3,140,600 | $3,095,000 | $2,406,800 | $2,582,500 | $2,363,200 |